Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 2
1948 1
1949 1
1950 2
1951 1
1952 4
1953 1
1955 3
1956 2
1957 1
1958 1
1960 1
1961 1
1962 1
1966 3
1967 1
1968 5
1969 2
1970 2
1971 4
1972 2
1973 2
1974 2
1975 1
1977 2
1978 2
1979 2
1980 3
1981 2
1982 1
1984 2
1985 7
1986 9
1987 11
1988 4
1989 9
1990 14
1991 3
1992 11
1993 13
1994 18
1995 8
1996 13
1997 9
1998 11
1999 10
2000 9
2001 7
2002 8
2003 13
2004 10
2005 6
2006 7
2007 13
2008 13
2009 15
2010 13
2011 12
2012 11
2013 24
2014 22
2015 23
2016 32
2017 40
2018 54
2019 59
2020 42
2021 49
2022 30
Text availability
Article attribute
Article type
Publication date

Search Results

671 results
Results by year
Filters applied: . Clear all
Page 1
Choroideremia.
MacDonald IM, Hume S, Zhai Y, Xu M. MacDonald IM, et al. 2003 Feb 21 [updated 2021 Mar 4]. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2022. 2003 Feb 21 [updated 2021 Mar 4]. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2022. PMID: 20301511 Free Books & Documents. Review.
CLINICAL CHARACTERISTICS: Choroideremia (CHM) is characterized by progressive chorioretinal degeneration in affected males and milder signs in heterozygous (carrier) females. ...Once the CHM pathogenic variant has been identified in an affected family member, carrier testi …
CLINICAL CHARACTERISTICS: Choroideremia (CHM) is characterized by progressive chorioretinal degeneration in affected males and milder …
Choroideremia.
Dimopoulos IS, Radziwon A, St Laurent CD, MacDonald IM. Dimopoulos IS, et al. Curr Opin Ophthalmol. 2017 Sep;28(5):410-415. doi: 10.1097/ICU.0000000000000392. Curr Opin Ophthalmol. 2017. PMID: 28520608 Review.
PURPOSE OF REVIEW: Although much has been written to define the phenotype and genotype of choroideremia (CHM), research continues to provide new insights that serve to better understand its pathogenesis and the directions for potential experimental therapies. ...
PURPOSE OF REVIEW: Although much has been written to define the phenotype and genotype of choroideremia (CHM), research continues to …
CHOROIDEREMIA: Retinal Degeneration With an Unmet Need.
Pennesi ME, Birch DG, Duncan JL, Bennett J, Girach A. Pennesi ME, et al. Retina. 2019 Nov;39(11):2059-2069. doi: 10.1097/IAE.0000000000002553. Retina. 2019. PMID: 31021898 Free PMC article. Review.
PURPOSE: Choroideremia is an incurable, X-linked, recessive retinal dystrophy caused by loss of function mutations in the CHM gene. ...METHODS: We review the patient journey, societal impact, and emerging treatments for patients with choroideremia. RESULTS: Its rela …
PURPOSE: Choroideremia is an incurable, X-linked, recessive retinal dystrophy caused by loss of function mutations in the CHM gene. . …
X-linked Choroideremia.
Tsang SH, Sharma T. Tsang SH, et al. Adv Exp Med Biol. 2018;1085:37-42. doi: 10.1007/978-3-319-95046-4_9. Adv Exp Med Biol. 2018. PMID: 30578482 Review.
Choroideremia (CHM) is the most common X-linked hereditary choroidal dystrophy, characterized by progressive degeneration of the choriocapillaris, retinal pigment epithelium (RPE), and retina. ...
Choroideremia (CHM) is the most common X-linked hereditary choroidal dystrophy, characterized by progressive degeneration of the chor
Molecular Therapies for Choroideremia.
Cehajic Kapetanovic J, Barnard AR, MacLaren RE. Cehajic Kapetanovic J, et al. Genes (Basel). 2019 Sep 23;10(10):738. doi: 10.3390/genes10100738. Genes (Basel). 2019. PMID: 31548516 Free PMC article. Review.
This chapter discusses new insights into clinical phenotyping and molecular genetic testing in choroideremia with review of molecular mechanisms implicated in its pathogenesis. ...Alternative molecular therapies are discussed including suitability of CRISPR gene editing, s …
This chapter discusses new insights into clinical phenotyping and molecular genetic testing in choroideremia with review of molecular …
Choroideremia Gene Therapy.
Lam BL, Davis JL, Gregori NZ. Lam BL, et al. Int Ophthalmol Clin. 2021 Oct 1;61(4):185-193. doi: 10.1097/IIO.0000000000000385. Int Ophthalmol Clin. 2021. PMID: 34584056 Free PMC article. No abstract available.
Multimodal Imaging in Choroideremia.
Foote KG, Roorda A, Duncan JL. Foote KG, et al. Adv Exp Med Biol. 2019;1185:139-143. doi: 10.1007/978-3-030-27378-1_23. Adv Exp Med Biol. 2019. PMID: 31884602 Free PMC article. Review.
Choroideremia (CHM) is associated with progressive degeneration of the retinal pigment epithelium (RPE), choriocapillaris (CC), and photoreceptors. ...
Choroideremia (CHM) is associated with progressive degeneration of the retinal pigment epithelium (RPE), choriocapillaris (CC), and p
Choroideremia: molecular mechanisms and therapies.
Sarkar H, Moosajee M. Sarkar H, et al. Trends Mol Med. 2022 May;28(5):378-387. doi: 10.1016/j.molmed.2022.02.011. Epub 2022 Mar 24. Trends Mol Med. 2022. PMID: 35341685 Review.
Choroideremia (CHM) is a monogenic X-linked chorioretinal dystrophy affecting the photoreceptors, retinal pigment epithelium (RPE), and choroid; it is caused by mutations involving the CHM gene. ...
Choroideremia (CHM) is a monogenic X-linked chorioretinal dystrophy affecting the photoreceptors, retinal pigment epithelium (RPE), a
Choroideremia: molecular mechanisms and development of AAV gene therapy.
Patrício MI, Barnard AR, Xue K, MacLaren RE. Patrício MI, et al. Expert Opin Biol Ther. 2018 Jul;18(7):807-820. doi: 10.1080/14712598.2018.1484448. Epub 2018 Jun 22. Expert Opin Biol Ther. 2018. PMID: 29932012 Review.
INTRODUCTION: Choroideremia is an X-linked inherited retinal degeneration that causes blindness in afflicted males by middle age. ...AREAS COVERED: The mechanism by which mutations in CHM cause choroideremia is still under debate. Here we describe the molecular defe …
INTRODUCTION: Choroideremia is an X-linked inherited retinal degeneration that causes blindness in afflicted males by middle age. ... …
Choroideremia: Update On Clinical Features And Emerging Treatments.
Brambati M, Borrelli E, Sacconi R, Bandello F, Querques G. Brambati M, et al. Clin Ophthalmol. 2019 Nov 18;13:2225-2231. doi: 10.2147/OPTH.S195564. eCollection 2019. Clin Ophthalmol. 2019. PMID: 31819346 Free PMC article. Review.
Choroideremia (CHM) is an X-linked chorioretinal dystrophy characterized by progressive degeneration of the choroid, retinal pigment epithelium and retina. ...In this article, a review of the salient pathogenetic features of choroideremia, essential for the proper i
Choroideremia (CHM) is an X-linked chorioretinal dystrophy characterized by progressive degeneration of the choroid, retinal pigment
671 results